Return to Article Details
QBD-BASED RP-UPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ATEZOLIZUMAB AND HYALURONIDASE IN CANCER DRUG FORMULATIONS